SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-004946
Filing Date
2017-05-11
Accepted
2017-05-11 16:16:11
Documents
56
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0317_soligenixinc.htm 10-Q 476147
2 CERTIFICATION f10q0317ex31i_soligenixinc.htm EX-31.1 14130
3 CERTIFICATION f10q0317ex31ii_soligenixinc.htm EX-31.2 14135
4 CERTIFICATION f10q0317ex32i_soligenixinc.htm EX-32.1 5097
5 CERTIFICATION f10q0317ex32ii_soligenixinc.htm EX-32.2 5056
  Complete submission text file 0001213900-17-004946.txt   2862920

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE sngx-20170331.xml EX-101.INS 499160
7 XBRL SCHEMA FILE sngx-20170331.xsd EX-101.SCH 31981
8 XBRL CALCULATION FILE sngx-20170331_cal.xml EX-101.CAL 30550
9 XBRL DEFINITION FILE sngx-20170331_def.xml EX-101.DEF 86380
10 XBRL LABEL FILE sngx-20170331_lab.xml EX-101.LAB 303740
11 XBRL PRESENTATION FILE sngx-20170331_pre.xml EX-101.PRE 187701
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14778 | Film No.: 17834480
SIC: 2834 Pharmaceutical Preparations